Population and Public Health

G42 Healthcare has partnered with Seegene to offer its new Seegene Mobile Station to various territories across the Middle East and North Africa. Each station can conduct up to 2,000 tests per day.

The funds will be used to accelerate the expansion of its digital care platform for respiratory health. 

The “first of its kind” institution aims at enhancing local genomic research, and diagnosing and treating patients with genetic disorders. Its launch coincides with the formation of the board of the Emirati Genome Program.

The Abu Dhabi-based company launched the service following requests by patients, it revealed. Starting 15 June, Abu Dhabi will restrict access to public places to those who have been vaccinated against COVID-19, or recently tested negative.

EndoArt successfully passed clinical trials, gaining China’s Innovative Device Status and FDA approval.

A new white paper from HIMSS suggests that the smartphone can hold the key to delivering capacity and enabling an innovative approach to rapid antigen testing as governments continue to wrestle with the impact of the COVID-19 pandemic.

The global health service company has launched a region-specific offering aimed at “SMEs, corporates and government organisations” within the country.

The agreement will focus on improving solutions across Aster’s entities in the United Arab Emirates (UAE), the Kingdom of Saudi Arabia (KSA), Qatar, and Oman.

Digital health experts from the UK will join the debate on how healthcare can evolve beyond COVID.

Dr. Jeffrey Vergales, a pediatric cardiologist at UVA Children’s, will be presenting at HIMSS21 on Aug. 10.